Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02205398
Title	Study of Safety and Efficacy of INC280 and Cetuximab, in Adult c-MET Positive mCRC and HNSCC Patients After Progression on Cetuximab or Panitumumab Therapy
Recruitment	Terminated
Gender	both
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	Novartis Pharmaceuticals
Indications	colorectal cancer head and neck squamous cell carcinoma
Therapies	Capmatinib + Cetuximab
Age Groups:	adult
Covered Countries	USA \| ITA \| FRA \| ESP \| DEU \| CAN \| BEL